EPCAM and breast carcinoma: In addition, transformation of human EpCAM+/CD10−/CD49f + luminal progenitors derived from reduction mammoplasties established tumors with features similar to basal-like breast cancer, including reduced ESR1 and greater K14 expression than tumors derived from differentiated luminal cells [54].